Articles

On Developing an OpEx Culture at Elan

Elan's head of manufacturing, Kevin Brady, talks about what works, and why.
Post Date: 05/16/2011
Author: Paul Thomas, Senior Editor

Digital Insights: Go Green...Stay Green

With all the online green manufacturing resources, there’s no excuse not to.
Post Date: 05/16/2011
Author: Michele Vaccarello Wagner, Senior Digital Editor

FDA's Biopharma Approvals Doubled Last Decade, According to Tufts Report

U.S. regulatory approvals for new biopharmaceuticals nearly doubled in the last decade, compared to the 1990s, according to the Tufts Center for the Study of Drug Development, but drug developers "face substantial challenges" if they are to maintain that pace, the study's author says.
Post Date: 05/11/2011
Author:

Pfizer Reinvents Lean in the Lab

At the core of missed opportunities in pharma QC/QA is a subtle misunderstanding of the real intent of Lean.
Post Date: 05/04/2011
Author: Lorcan Mannion, Operations Practice Manager, BSM Ireland, and Ciarán Crosbie,...

Meeting the Supply Management Challenge

To manage increasingly complex supplier networks, pharmaceutical companies must develop new capabilities, organizational structures and management tools.
Post Date: 05/04/2011
Author: Ric Philips and Kevin Sachs, McKinsey & Co.

Can You See the Real QbD?

Rather than helping, could the current brand of pharmaceutical Quality by Design be acting as a distraction and deterrent to quality?
Post Date: 05/03/2011
Author: Gawayne Mahboubian-Jones, Program Manager for Excellence in Science and ...

Prioritizing Pharma’s Green Engineering Needs

Continuous processing and bioprocesses deserve more attention, says GSK’s Conchita Jimenez-Gonzalez, who chairs the ACS GCI Pharma Roundtable.
Post Date: 04/19/2011
Author: Paul Thomas, Senior Editor

Therapeutic Dose: Greening the Pharma Lab

Reducing environmental impact may not have been vendors’ primary goal, but it has been a welcome result, allowing dramatic cost savings.
Post Date: 04/11/2011
Author: Emil Ciurczak, Contribuing Editor

Abbott: Building a Stable Foundation for Continuous Improvement

Abbott's Continuous Improvement Manager shares best practices on how to prepare an organization for Lean and Six Sigma projects.
Post Date: 04/06/2011
Author: Paul Thomas, Senior Editor

Vital Links: Supplier Risk Monitoring

Organizations which adopt and implement a comprehensive supplier risk monitoring program will have visibility into a broad spectrum of overall supplier risk factors, not just compliance.
Post Date: 03/15/2011
Author: Scott Chizzo, President & Chief Consultant, Maxiom Group, Frank Gaibor, ...

Real-Time Release: It’s Time for Action, Not Debate

Before arguing about Just in Time (JIT) solutions and how to define them, shouldn’t we look at why we need them, and form a plan?
Post Date: 03/15/2011
Author: Ali Afnan, Principal, Step Change Pharma, Inc.

PharmaView: Should Pharma Fear the Supply Chain of the Future?

As paradigms shift, we also need paradigm expansion.
Post Date: 03/15/2011
Author: Paul Thomas, Senior Editor

Building a Modeling Culture in Manufacturing at Pfizer

At Pfizer, the value of models is not in mimicking reality, but in illustrating the interactions between people, equipment, materials, and time.
Post Date: 02/17/2011
Author: Joe Cancelarich, Director of Global Engineering, Pfizer

Quality Circle: A Primer for Business Performance Management

What has emerged from Pharma's tough journey is a newfound appreciation for business performance.
Post Date: 02/02/2011
Author: Bikash Chatterjee, President and CTO, Pharmatech Associates

Is Pharma Stuck on the Way to Six Sigma?

Six Sigma and OpEx now take a back seat to cost-cutting, yet experts say cost reduction will, ultimately, drive the industry’s transformation
Post Date: 01/11/2011
Author: Agnes Shanley, Editor in Chief

Career Security: Can a Pharma "Lab Rat" Survive in the Wild?

If you were let go from your job, could you survive?
Post Date: 10/20/2010
Author: Michael Steiner, CFP, CPA, RegentAtlantic Capital, LLC

Using Lean to Catalyze Pharmaceutical Product Development

R&D must harness its inherent scientific horsepower and apply it through statistically unbiased experimental designs.
Post Date: 10/18/2010
Author: Bikash Chatterjee, President and CTO, Pharmatech Associates

Temporary Workers: Pharma's Contingency Planning

Consultant Steve Sawin answers our questions about managing contingent labor.
Post Date: 10/18/2010
Author: Paul Thomas, Senior Editor

Building a Culture of Training: Best Practices from Shire HGT

A discussion with Bill Ciambrone, Senior Vice President of Technical Operations for Shire Human Genetic Therapies, about critical issues in workforce training today.
Post Date: 10/18/2010
Author: Paul Thomas, Senior Editor

Reducing Variability in the Pharma Workforce

How drug manufacturers can overcome the "44th Hour Problem" and other challenges associated with a variable workforce.
Post Date: 10/18/2010
Author: Paul Thomas, Senior Editor